Pfizer dividend yield PFE
Dividends per share over the last twelve months divided by the share price, since 1972.
- Today, Oct 23, 2026
- 5.73%
- 10-year median
- 4.0%
- Against its 10-year history
- 73rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 2.6% to 7.7%
- Peer median
- 2.3%
Pfizer pays 5.73% of its share price in dividends over a year, as of Oct 23, 2026.
That is above its ten-year median of 4.0%, higher than on 73% of days in the last ten years.
Over that time it ranged from 2.6% in Dec 2021 to 7.7% in Apr 2025.
The median for 8 large drugmakers of a similar size is 2.3%.
Dividend yield over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 5.7% | 5.7% | 7.1% |
| 2025 | 6.9% | 6.2% | 7.7% |
| 2024 | 6.3% | 5.4% | 6.8% |
| 2023 | 5.7% | 3.1% | 6.2% |
| 2022 | 3.1% | 2.8% | 3.8% |
| 2021 | 2.6% | 2.6% | 4.6% |
| 2020 | 4.1% | 3.7% | 5.3% |
| 2019 | 3.9% | 3.3% | 4.4% |
| 2018 | 3.3% | 3.1% | 4.0% |
| 2017 | 3.7% | 3.6% | 4.0% |
| 2016 | 3.7% | 3.2% | 4.1% |
| 2015 | 3.7% | 3.2% | 3.7% |
| 2014 | 3.5% | 3.2% | 3.9% |
| 2013 | 3.3% | 3.1% | 3.6% |
| 2012 | 3.7% | 3.5% | 4.0% |
| 2011 | 3.7% | 3.7% | 4.5% |
| 2010 | 4.3% | 3.8% | 5.1% |
| 2009 | 4.5% | 4.4% | 10.4% |
| 2008 | 7.5% | 4.8% | 8.3% |
| 2007 | 5.1% | 3.5% | 5.1% |
Against its peers
Companies in Drug Manufacturers - General nearest Pfizer's size, closest first, today.
| Company | Dividend yield |
|---|---|
| PFEPfizer | 5.73% |
| GILDGilead Sciences | 2.08% |
| BMYBristol-Myers Squibb | 4.10% |
| AMGNAmgen | 2.26% |
| MRKMerck | 2.34% |
| ABBVAbbVie | 2.42% |
| JNJJohnson & Johnson | 2.00% |
| BIIBBiogen | n/m |
| LLYEli Lilly and | 0.53% |
| Peer median | 2.26% |
Where Pfizer ranks
What the dividend yield tells you
Yearly dividends per share divided by the share price.
A yield that suddenly looks high often means the price fell because the dividend is at risk.
More on Pfizer
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.